Article info

Download PDFPDF
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial

Authors

  1. Correspondence to Dr Yong Yuan; yuany{at}zsph.com
View Full Text

Citation

Wang W, He S, Zhang W, et al
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial

Publication history

  • Received March 18, 2024
  • Accepted May 8, 2024
  • First published May 22, 2024.
Online issue publication 
September 30, 2024

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.